An interdisciplinary team reported DNA methylation signatures in maternal blood that associate with gestational diabetes at multiple pregnancy stages. The study tracked methylation changes longitudinally and identified loci consistently altered in women who develop gestational diabetes, offering potential biomarkers for early detection. Authors propose that persistent methylation marks could inform risk stratification and mechanistic studies into maternal‑fetal metabolic programming.